Skip to content

NeuroQuant NQ

by Cortechs Labs Inc

NeuroQuant NQ is a Class II device made by Cortechs Labs Inc, cleared under FDA 510(k) K170981 on 7 Sep 2017 (1 earlier submission) and listed in FDA GUDID since 24 Sep 2016 (UDI-DI 00863725000300), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK170981 Date7 Sep 2017DecidedStatusActive
United StatesGUDID listing Number00863725000300 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

Across registries

2 registries list this device

  • FDA 510(k) K170981 decided 7 Sep 2017 Active· +1 more in the status table
  • FDA GUDID UDI-DI 00863725000300 listed 24 Sep 2016 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K061855
  2. Listed FDA GUDID 00863725000300
  3. Cleared FDA 510(k) K170981

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
NeuroQuant
Generic name
MRI system application software
Model / reference
NQ
Primary DI / UDI-DI
00863725000300
510(k) Number
FDA product code
LLZ
GMDN term
MRI system application software
Device class
Class II
Regulation number
892.2050
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under MRI system application software.

Other devices from Cortechs Labs Inc

See all devices from Cortechs Labs Inc →

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)